UFP Technologies, Inc.
UFPT
NASDAQ·Healthcare·Medical - Devices·Mkt cap $2.2B
$288.79
▲ +0.79%
P/E
31.02
Mkt Cap
$2.2B
52-Wk Range
$173.86–$338.71
52-Week Range
$173.86 - $338.71
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 40.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in foam, film, and plastic material science with 60+ year track record
- Custom manufacturing capabilities enabling high-barrier entry for competitors
- Established relationships with major medical device OEMs and long-term supply contracts
- Diversified customer base across medical, aerospace, defense, and industrial markets reduces concentration risk
Bear Case
2 risks
- Average volatility.
- Premium valuation to Medical Devices peers
Growth
Stable outlook
Rising demand for single-use medical devices driven by infection control and patient safety regulations
Value
Premium valuation to Medical Devices peers
Momentum
Hot
+27.4% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying UFPT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 3, 2026
Reported EPS of $2.69 vs $2.31 consensus (+16.4% surprise). Revenue of $174.0M vs $159.4M expected (+9.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+16.4%
Revenue trend · last 8Q
—
+42%
+41%
+37%
+6%
+3%
+4%
+15%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$145.2M
$144.1M
$148.1M
$151.2M
$154.6M
$148.9M
$154.2M
$174.0M
Margins · last 8Q
Gross
29.3%
Operating
16.2%
Profit
12.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How UFPT stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related